[Retracted] Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer

Table 2

Comparison of serum tumor markers.

Group	Period	Observation group	Control group
		(n = 58)	(n = 58)
sIL-2R (IU/ml)	Before	763.02 136.24	760.91 135.43
	After	649.14 115.68	528.32 93.61
sICAM-1 (μg/l)	Before	513.21 145.76	516.86 148.97
	After	359.42 112.64	218.54 79.36
VEGF (ng/ml)	Before	570.43 106.94	573.54 109.83
	After	403.21 84.55	238.17 69.31
CEA (ng/ml)	Before	38.20 10.93	38.41 10.89
	After	23.01 8.06	15.73 4.88